Venous Congestion in Surgical Flaps
FDA-cleared application: medicinal leech therapy to relieve venous congestion in compromised tissue flaps awaiting vascular ingrowth.
Patient Summary
- Is this FDA-cleared for this use?
- Yes — FDA-cleared under K040187 (June 21, 2004) for medicinal leech application to relieve venous congestion in microsurgical reconstructive procedures.
- What evidence exists?
- This is the one situation where the FDA has officially cleared medicinal leeches as a medical device. Hospital studies (retrospective series totaling 400+ patients) show that when leech therapy is started within 24 hours of congestion, 70 to 85 percent of threatened flaps survive that would otherwise have been lost. It does not work for flaps with poor artery blood flow — that is a surgical problem leeches cannot solve.
- Main risks
- Heavy bleeding from the bite site for 6 to 10 hours after each leech detaches
- Need for a blood transfusion if many leeches are used over several days (about 1 in 5 to 1 in 3 patients)
- Aeromonas hydrophila infection from the leech's gut bacteria (your team gives a preventive antibiotic such as ciprofloxacin)
- Loss of the flap anyway if the underlying artery problem cannot be fixed
- Allergic reaction to leech saliva proteins (rare but possible)
- Scarring from the bite marks once they heal
- Who should not consider this
- Patients on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- People with hemophilia or any inherited bleeding disorder
- Patients with severe anemia (hemoglobin under 10 g/dL) who cannot tolerate more blood loss
- Patients with an active bloodstream infection or sepsis
- Patients allergic to ciprofloxacin or other antibiotics needed to prevent Aeromonas infection
- Patients whose flap has lost arterial blood supply (this needs surgical repair first, not leeches)
- What to ask your clinician
- Is the problem with my flap a vein issue or an artery issue? Leeches only help with vein problems.
- What antibiotic will I get to prevent Aeromonas infection, and how long will I take it?
- How often will my blood count be checked, and at what hemoglobin level would you transfuse me?
- What is the expected timeline — how many days of leech therapy do you estimate before the flap can drain on its own?
- What signs should my family and I watch for that would mean the treatment is not working?
- Who is responsible for placing and removing the leeches, and how often will they check on me?
- What happens to the used leeches afterward, and is there any disposal concern?
- When to seek urgent care
- Bleeding from a bite site that soaks through more than one dressing per hour, or any bleeding lasting more than 24 hours after the leech detached
- Spreading redness, warmth, swelling, or pus around the bite area or the flap
- Fever over 38.0 C / 100.4 F or chills
- The flap becoming darker, colder, or harder despite leech therapy
- Hives, swelling of the face or tongue, difficulty breathing, or any sign of allergic reaction
What this does NOT mean
- It does not mean the flap is guaranteed to survive — even with leeches, about 15 to 30 percent of severely congested flaps are still lost, usually because of an artery problem that leeches cannot fix.
- It does not mean leeches cure anything by themselves — they buy time (about 3 to 7 days) while your body grows new veins into the flap.
- It does not mean this is a treatment you can do at home — it is an inpatient hospital therapy with continuous monitoring of blood counts.
- It does not mean medicinal leeches are the same as wild leeches — they are FDA-cleared, lab-raised under sterile conditions, and used only once.
Safety cross-references
Clinical Profile
- Category
- Surgical reconstruction
- ICD-10
- T87.40, T87.41, T87.42, T87.43, T87.44, I87.8
- Safety tier
- High
Evidence Summary
Venous congestion in pedicled and free flaps is the most common cause of postoperative flap failure, occurring in 5-10% of microsurgical reconstructions. Hirudo medicinalis received FDA clearance (K040187, June 21 2004) specifically for relief of venous congestion. The mechanism is twofold: mechanical drainage from the bite wound (oozing for 6-10 hours after detachment) and pharmacologic action of hirudin, calin, and hyaluronidase reducing local thrombogenesis. Multiple retrospective series demonstrate flap salvage rates of 70-85% when initiated within 24 hours of congestion onset. Failure to thrive remains driven by arterial compromise (which leeches cannot address) and delayed initiation.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Whitaker IS et al. (2012), n=277 · PMID 22407551 · ASH analysis →
- Nguyen MQ et al. (2012), n=39 · PMID 22473683 · ASH analysis →
- Chepeha DB et al. (2002), n=8 · PMID 12162779 · ASH analysis →
- Systematic Review: 1 (33%)
- Cohort: 1 (33%)
- Case Series: 1 (33%)
Detailed Trial Entries
14 trials indexed in the ASH RCT Library with full Study Profile, GRADE rating, and clinical implications:
- Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011) · Microsurgery · n=35 · GRADE low
- Comparisons of medicinal leech therapy with venous catheterization in the treatment of venous congestion of the sural flap
Mozafari N, Ghazisaidi MR, Hosseini SN, Abdolzadeh M (2010) · Microsurgery · n=56 · GRADE low
- Chemical and mechanical alternatives to leech therapy: a systematic review and critical appraisal
Azzopardi EA, Whitaker IS, Rozen WM, Naderi N, Kon M (2011) · Journal of Reconstructive Microsurgery · n=25 · GRADE low
- Determining the appropriate number and duration of leech therapy in congested tissues using tissue spectrophotometry and laser Doppler flowmetry
Rothenberger J, Petersen W, Schaller HE, Held M (2016) · Wound Repair and Regeneration · n=12 · GRADE low
- HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW
Heinz P, Tvrdý P, Pink R, Dvořák Z, Michl P (2020) · Acta Chirurgiae Plasticae · n=0 · GRADE very-low
- Investigating the therapeutic potential of medical leech and leech saliva extract in flap survival: an in vivo study using rats
Ünal K, Emre Erol M, Dayanır D, Deniz E, Ayhan H, Fındıkçıoğlu K (2025) · Journal of Complementary & Integrative Medicine · n=0 · GRADE very-low
- Management of complications and compromised free flaps following major head and neck surgery
Kucur C, Durmus K, Uysal IO, Old M, Agrawal A, Arshad H, Teknos TN, Ozer E (2015) · European Archives of Oto-Rhino-Laryngology · n=260 · GRADE low
- Current concepts in salvage procedures for failing microvascular flaps: is there a superior technique? Insights from a systematic review of the literature
Troeltzsch M, Troeltzsch M, Probst FA, Ristow O, Ehrenfeld M, Otto S (2016) · International Journal of Oral and Maxillofacial Surgery · n=330 · GRADE low
- Leech Therapy in the Head and Neck
Moen G, Dillon J (2025) · Journal of Oral and Maxillofacial Surgery · n=7 · GRADE very-low
- A Disaster and Salvage Revisited: Chest Wall Reconstruction (5-Rib Defect) With Gore-Tex, TRAM Flap, and Salvage With Leeches
Gatti JE (2026) · Annals of Plastic Surgery · n=1 · GRADE very-low
- Salvage of pedicled anterolateral thigh flap for closure of a massive full-thickness abdominal wall defect using modified Perez protocol for chemical leeching
Babalola OF, Udensi R (2026) · Journal of Surgical Case Reports · n=1 · GRADE very-low
- Effect of Perioperative Antithrombotics on Head and Neck Microvascular Free Flap Survival After Anastomotic Revision
Bishop JL, Vasudev M, Garcia N, Heslop G, Pham TT, Hicks MD, Chowdhury F, Grayson JW, Goddard JA, Tjoa T, Haidar Y, Thomas CM (2023) · Otolaryngology — Head and Neck Surgery (American Academy of Otolaryngology) · n=843 · GRADE low
- Reconstruction of the soft tissue defects of foot and ankle with neural-island flaps: mono-institutional case series
Sonmez E, Safak T (2011) · Journal of Reconstructive Microsurgery · n=20 · GRADE very-low
- Reverse posterior interosseous flap for defects of the dorsal ulnar wrist using previously burned and recently grafted skin
Baylan JM, Chambers JA, McMullin N, Fletcher JL, Sinha I, Lundy J, King BT, Chan RK (2015) · Burns · n=3 · GRADE very-low
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Arterial insufficiency to the flap (must address before leeching)
- Patient unable to consent to potential transfusion requirement
Related ASH Compounds
Leech molecules and hirudin-derived drugs mentioned for this condition, each profiled in the ASH compound registry:
Related Conditions
Microsurgical Replantation (Digit / Ear / Scalp)
FDA-cleared application: post-replantation venous decompression in digits, ears, scalp, and partial avulsion injuries.
Breast Reconstruction Flap Salvage
FDA-cleared application: venous decompression of compromised DIEP, TRAM, and latissimus dorsi flaps in post-mastectomy reconstruction.